Scholarlink

Purpose <p>To report a multicenter experience with minimally invasive surgery (MIS) for pediatric urachal anomalies and to compare laparoscopic versus robotic-assisted approaches.</p> Methods <p>A retrospective review was performed of all patients with urachal remnants treated with MIS between January 2019 and January 2025. Demographic, perioperative, and outcome data were collected and analyzed.</p> Results <p>Twenty-three patients (13 males) with a median age of 5.9 years (range 6 months–14 years) underwent surgery for symptomatic urachal anomalies. Fifteen patients (65.2%) were treated laparoscopically and eight (34.8%) robotically. Complete excision was achieved in all cases. Median operative time was 45&#xa0;min (range 33–73). A bladder catheter was maintained for 24&#xa0;h postoperatively, and all patients were discharged within 48–72&#xa0;h. Histopathology confirmed urachal remnants without evidence of malignancy. No intraoperative complications occurred. One minor postoperative complication (Clavien–Dindo I) was reported. Median follow-up was 2 years (range 5 months–6 years).</p> Conclusion <p>MIS represents the gold standard for the treatment of urachal remnants. Both laparoscopy and robotic-assisted surgery are safe and effective. The robotic approach may offer ergonomic and technical advantages. Indocyanine green (ICG) fluorescence appears to facilitate lesion identification and guide dissection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Laparoscopic vs robotic-assisted surgery for treating urachal anomalies in pediatric patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月27日

查看全文
  • Ciro Esposito,
  • Fulvia Del Conte,
  • Daniele Alberti,
  • Claudia Di Mento,
  • Marco Castagnetti,
  • Francesco Tedesco,
  • Roberta Guglielmini,
  • Giovanni Boroni,
  • Michele Bosisio,
  • Francesca Carraturo,
  • Tristan Till,
  • Vincenzo Coppola,
  • Giorgia Esposito,
  • Maria Escolino

摘要

Purpose

To report a multicenter experience with minimally invasive surgery (MIS) for pediatric urachal anomalies and to compare laparoscopic versus robotic-assisted approaches.

Methods

A retrospective review was performed of all patients with urachal remnants treated with MIS between January 2019 and January 2025. Demographic, perioperative, and outcome data were collected and analyzed.

Results

Twenty-three patients (13 males) with a median age of 5.9 years (range 6 months–14 years) underwent surgery for symptomatic urachal anomalies. Fifteen patients (65.2%) were treated laparoscopically and eight (34.8%) robotically. Complete excision was achieved in all cases. Median operative time was 45 min (range 33–73). A bladder catheter was maintained for 24 h postoperatively, and all patients were discharged within 48–72 h. Histopathology confirmed urachal remnants without evidence of malignancy. No intraoperative complications occurred. One minor postoperative complication (Clavien–Dindo I) was reported. Median follow-up was 2 years (range 5 months–6 years).

Conclusion

MIS represents the gold standard for the treatment of urachal remnants. Both laparoscopy and robotic-assisted surgery are safe and effective. The robotic approach may offer ergonomic and technical advantages. Indocyanine green (ICG) fluorescence appears to facilitate lesion identification and guide dissection.